Immune complexes in preeclampsia and normal pregnancy.
We determined in normal nonpregnant (group I) and normal pregnant (group II) women and in patients with preeclampsia (group III): (1) immunoglobulins and complement C3b associated with polymorphonuclear leukocytes and platelet surfaces in an attempt to evaluate the interaction in vivo of immune complexes with the membranes of these cells; (2) the occurrence of circulating immune complexes; (3) the serum levels of immunoglobulins, C3, and C4; and (4) the plasma levels of complement C3d. In patients with preeclampsia (group III), the percentages of polymorphonuclear leukocytes and platelets positive for membrane-bound IgG, IgM, IgA, and C3 were significantly higher than the percentages in groups I and II. In group III, there also was a significant increase in circulating immune complexes, as compared to groups I and II. However, circulating immune complexes were also present in significant amounts in normal pregnancy (group II). The plasma levels of complement C3d were markedly increased in the most severe cases of preeclampsia.
D000328:Adult; D000936:Antigen-Antibody Complex / Q000032:analysis*; D001792:Blood Platelets / Q000187:drug effects / Q000276:immunology; D003167:Complement Activation; D003176:Complement C3 / Q000032:analysis; D003179:Complement C3b / Q000276:immunology; D015933:Complement C3d; D003181:Complement C4 / Q000032:analysis; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007136:Immunoglobulins / Q000276:immunology; D007841:Latex Fixation Tests; D009504:Neutrophils / Q000276:immunology; D011225:Pre-Eclampsia / Q000276:immunology*; D011247:Pregnancy; D012310:Ristocetin / Q000494:pharmacology
D000936:Antigen-Antibody Complex; D003176:Complement C3; D003181:Complement C4; D007136:Immunoglobulins; D012310:Ristocetin; D003179:Complement C3b; D015933:Complement C3d